JAMA Health Forum @jamahealthforum.com · 08/08/2026Among high-risk therapeutic #MedicalDevices approved through the US Food and Drug Administration premarket approval pathway, more than 1-third were later subject to serious recalls, supporting stronger postmarket surveillance. ja.ma/4z5Nh3u 002
